BIONTECH: Following positive updates increasing sales projection for Comirnaty | NEUTRAL vs. BUY | USD206 VS. 135
BIONTECH - NEUTRAL vs. BUY | USD206 VS. 135 (+2%)Following positive updates increasing sales projection for Comirnaty
Increasing sales guidance for 2021 and beyond
Manufacturing and vaccine stability updates
Two additional boosters per year could be required in the near future
Financial model update
Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.